Bio-Rad Laboratories - 39 Year Stock Price History | BIO

Historical daily share price chart and data for Bio-Rad Laboratories since 1980 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Bio-Rad Laboratories as of February 15, 2019 is 270.34.
Bio-Rad Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 243.2556 228.0800 270.3400 224.3000 270.3400 16.42%
2018 277.5328 241.4200 326.1500 220.1000 232.2200 -2.70%
2017 219.5752 182.9100 271.3000 182.9100 238.6700 30.94%
2016 149.1690 136.1900 183.4600 123.9300 182.2800 31.46%
2015 137.5260 120.3500 151.9300 113.7700 138.6600 15.01%
2014 120.8765 122.6500 133.7300 106.4800 120.5600 -2.47%
2013 118.6682 107.4600 126.0000 107.4600 123.6100 17.67%
2012 102.7218 98.0800 114.2500 92.3000 105.0500 9.38%
2011 108.0200 105.3200 126.3400 87.5400 96.0400 -7.52%
2010 94.7088 97.8700 113.6300 81.5000 103.8500 7.66%
2009 78.5782 74.4700 100.4600 53.1000 96.4600 28.08%
2008 87.1254 99.9700 108.1000 61.5200 75.3100 -27.32%
2007 82.9541 82.2200 107.5700 67.6700 103.6200 25.57%
2006 68.9380 65.4500 84.0100 57.2500 82.5200 26.10%
2005 55.5089 57.1700 66.9000 47.0600 65.4400 14.07%
2004 55.2252 58.4100 61.9000 50.0100 57.3700 -0.52%
2003 48.0377 38.2100 62.1500 33.4000 57.6700 49.02%
2002 39.7467 30.9000 50.5100 28.1250 38.7000 22.27%
2001 23.7924 16.0500 32.5250 15.0750 31.6500 99.06%
2000 12.9794 11.3100 16.7450 10.6250 15.9000 36.01%
1999 12.2611 10.3100 14.5000 9.4400 11.6900 11.33%
1998 13.1470 13.0600 16.8750 9.8750 10.5000 -19.60%
1997 13.5673 15.1900 16.3750 11.8100 13.0600 -12.93%
1996 14.6824 14.2067 18.3100 12.1250 15.0000 5.88%
1995 11.3630 9.1267 14.1667 8.4567 14.1667 53.15%
1994 6.4240 3.5000 9.6267 3.5000 9.2500 177.50%
1993 4.7750 5.7067 5.9167 3.3333 3.3333 -41.59%
1992 6.1821 6.4167 7.1267 5.3733 5.7067 -13.32%
1991 7.0525 6.0833 9.1667 5.5433 6.5833 6.76%
1990 5.8093 5.4167 7.6667 4.2067 6.1667 15.63%
1989 5.6551 5.7067 6.5433 4.7500 5.3333 -5.88%
1988 6.3804 5.2500 7.7067 4.9167 5.6667 11.48%
1987 7.6195 5.8733 10.6667 3.7500 5.0833 -11.59%
1986 5.9524 5.0556 7.6400 4.5556 5.7500 13.74%
1985 3.2334 2.1304 5.3067 2.1304 5.0556 137.31%
1984 2.2033 2.5007 2.5185 2.0741 2.1304 -14.81%
1983 2.3317 1.3511 2.8696 1.3511 2.5007 87.56%
1982 1.3124 1.5378 1.6104 0.8696 1.3333 -7.69%
1981 2.4659 2.9807 3.6667 1.2963 1.4444 -51.25%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $7.832B $2.160B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.916B 25.68
Medtronic (MDT) Ireland $122.526B 18.32
Stryker (SYK) United States $69.144B 25.38
Boston Scientific (BSX) United States $55.241B 26.97
Baxter (BAX) United States $38.548B 23.75
Zimmer Biomet Holdings (ZBH) United States $24.985B 16.03
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
ResMed (RMD) United States $14.250B 27.02
Canopy Growth (CGC) Canada $10.707B 0.00
Aurora Cannabis (ACB) Canada $7.090B 50.71
Hill-Rom Holdings (HRC) United States $6.904B 21.35
Perrigo (PRGO) Ireland $6.603B 10.02
ICU Medical (ICUI) United States $5.119B 28.52
Insulet (PODD) United States $5.012B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.563B 0.00
Haemonetics (HAE) United States $4.395B 38.99
Agios Pharmaceuticals (AGIO) United States $3.341B 0.00
Hutchison China MediTech (HCM) China $3.330B 0.00
Neogen (NEOG) United States $3.259B 50.06
NuVasive (NUVA) United States $3.008B 27.99
National Vision Holdings (EYE) United States $2.570B 49.72
Quidel (QDEL) United States $2.529B 22.88
Aphria (APHA) $2.274B 101.00
NxStage Medical (NXTM) United States $1.945B 0.00
AtriCure (ATRC) United States $1.269B 0.00
VAREX IMAGING (VREX) United States $1.196B 23.42
Phibro Animal Health (PAHC) United States $1.192B 17.13
Cardiovascular Systems (CSII) United States $1.151B 826.00
HEXO (HEXO) $1.127B 0.00
MacroGenics (MGNX) United States $0.893B 0.00
Cerus (CERS) United States $0.848B 0.00
PetIQ (PETQ) United States $0.821B 21.28
Evolus (EOLS) United States $0.744B 0.00
Surmodics (SRDX) United States $0.724B 105.35
NanoString Technologies (NSTG) United States $0.721B 0.00
Lantheus Holdings (LNTH) United States $0.711B 22.00
OraSure Technologies (OSUR) United States $0.707B 31.19
Omeros (OMER) United States $0.703B 0.00
Meridian Bioscience (VIVO) United States $0.698B 20.80
Eagle Pharmaceuticals (EGRX) United States $0.604B 19.39
Quanterix (QTRX) United States $0.491B 0.00
LeMaitre Vascular (LMAT) United States $0.486B 23.89
Owens & Minor (OMI) United States $0.470B 5.32
TG Therapeutics (TGTX) United States $0.390B 0.00
Insys Therapeutics (INSY) United States $0.355B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.98
BioLife Solutions (BLFS) United States $0.285B 385.00
Bovie Medical (APYX) United States $0.283B 0.00
Vapotherm (VAPO) United States $0.279B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.272B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.228B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.152B 0.00
Fonar (FONR) United States $0.147B 7.87
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.11
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.079B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.53
Conatus Pharmaceuticals (CNAT) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.033B 0.00
Senestech (SNES) United States $0.020B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14